Edwin M. Kania Jr., 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), bought 610,233 shares at $10.00 ($3.8M) on 2014-02-11, disclosed to the SEC on 2014-02-13.
Open-market purchase of $3.8M EBIO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 231,504 | $0 | 0.0% |
| 2 | $10.00 | 32,912 | $329K | 8.7% |
| 3 | $10.00 | 131,722 | $1.3M | 34.8% |
| 4 | $10.00 | 214,095 | $2.1M | 56.5% |
| Total | $6.21 avg | 610,233 | $3.8M | 100% |
| Filing → |
| MRNA | SELL | 2019-12-11 | $3.8M | — | Filing → |
| TMDX | BUY | 2019-05-06 | $533K | — | Filing → |
| SELB | SELL | 2017-05-16 | $3.7M | — | Filing → |